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DAPK2 regulates oxidative stress in cancer cells by
preserving mitochondrial function
CR Schlegel1, ML Georgiou1, MB Misterek1,2, S Stöcker1,3, ER Chater1, CE Munro1, OE Pardo1, MJ Seckl1 and AP Costa-Pereira*1
Death-associated protein kinase (DAPK) 2 is a serine/threonine kinase that belongs to the DAPK family. Although it shows
significant structural differences from DAPK1, the founding member of this protein family, DAPK2 is also thought to be a putative
tumour suppressor. Like DAPK1, it has been implicated in programmed cell death, the regulation of autophagy and diverse
developmental processes. In contrast to DAPK1, however, few mechanistic studies have been carried out on DAPK2 and the
majority of these have made use of tagged DAPK2, which almost invariably leads to overexpression of the protein. As a
consequence, physiological roles of this kinase are still poorly understood. Using two genetically distinct cancer cell lines as
models, we have identified a new role for DAPK2 in the regulation of mitochondrial integrity. RNA interference-mediated depletion
of DAPK2 leads to fundamental metabolic changes, including significantly decreased rate of oxidative phosphorylation in
combination with overall destabilised mitochondrial membrane potential. This phenotype is further corroborated by an increase in
the production of mitochondrial superoxide anions and increased oxidative stress. This then leads to the activation of classical
stress-activated kinases such as ERK, JNK and p38, which is observed on DAPK2 genetic ablation. Interestingly, the generation of
oxidative stress is further enhanced on overexpression of a kinase-dead DAPK2 mutant indicating that it is the kinase domain of
DAPK2 that is important to maintain mitochondrial integrity and, by inference, for cellular metabolism.
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Death-associated protein kinase (DAPK) 2 shares a high level
of homology within its kinase domain with the other two DAPK
family members, DAPK1 (DAPk) and DAPK3 (ZIPK/DLK).
Since the identification of DAPK1 by Kimchi and co-workers1
numerous studies have shown that DAPK1 functions as a
tumour suppressor, is linked to key events in autophagy and is
involved in mitochondrial maintenance2 and metabolism.3
DAPK2, which was characterised in 1999,4 is significantly
smaller than DAPK1, and it lacks ankyrin repeats, the
cytoskeletal binding domain and the death domain, all of
which are part of DAPK1’s unique structure.1 Several
functions have been ascribed to DAPK2 and they often
coincide with those of DAPK1. Like DAPK1, DAPK2 is also
involved in the formation of autophagic vesicles,5,6 modulation
of receptor induced cell death7–9 and several modes of
intrinsic apoptotic cell death.6 While epigenetic silencing of
DAPK1 has been reported in many different human
cancers,10,11 DAPK2 appears to be silenced mainly in
haematological disorders,12 although it has been shown to
modulate TRAIL-induced apoptosis in several cancer cell lines
of non-haematological origin.9 Most approaches used for
studying the role of DAPK2 used tagged DAPK2 and it is,
therefore, still unclear whether these functions are also carried
out by the native protein, expressed at much lower, endogen-
ous, levels.
DAPK1 has been shown to regulate mitochondrial integrity
and tomodulate themitochondrial membrane potential2 but, to
the best of our knowledge, no work has been carried out in this
respect with regard to DAPK2. Since DAPK1 and DAPK2
appear to share many functions and both are thought to
reside, at least partially, in the mitochondria, we hypothesised
that DAPK2 depletion regulated mitochondrial metabolism.
Mitochondrial dysfunction is characterised by the induction of
reactive oxygen species (ROS) in the cell.13 Ultimately,
dysfunctional mitochondria can no longer be powerhouses
of use to the cell and are, therefore, targeted for degradation.
Alternatively, their membranes can depolarise leading to the
release of cytochrome c, an early apoptotic process.14 Using
two distinct cancer cell types, namely U2OS osteosarcoma
and A549 non-small cell lung cancer cells,9,15 we show
that DAPK2 depletion increases the levels of intracellular
ROS, leads to mitochondrial depolarisation and impairs
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mitochondrial metabolism. DAPK2 thus exerts metabolic and
mitochondria-regulating functions, which have not been
described to date and that can explain why it is downregulated
in haematological malignancies,12,16,17 and involved in
modulating death-inducing signalling in solid tumours.9
Results
RNAi-mediated ablation of DAPK2 induces oxidative
stress and activates mitogen-activated protein kinases.
Although DAPK2 is structurally significantly different from
DAPK1, their kinase domains are highly homologous.18 As
DAPK1 has been shown to be involved in mitochondrial
regulation,2 we asked whether DAPK2 could also modulate
the level of cellular oxidative stress. For that purpose, DAPK2
was targeted with a pool of short interfering (si) RNA
oligonucleotides (henceforth referred to as siDAPK2), pre-
viously validated in our laboratory (Supplementary Figure S1
and Schlegel et al9). U2OS osteosarcoma and A549 lung
cancer cells were transfected with either a control non-
targeting siRNA oligonucleotide (siNS) or with siDAPK2 and
proteins were analysed by sodium dodecyl sulphate-PAGE
(SDS-PAGE). Quantitative western blots (qWB) in Figure 1
show the efficiency of the knockdown of DAPK2 in U2OS
(Figure 1a) and A549 (Figure 1e) cells, when compared with
the control siNS-transfected cells.
Oxidative stress was studied by flow cytometry in cells
transfected with siNS, siDAPK2 or challenged with H2O2
(positive control for the production of ROS). General oxidative
stress was analysed using the chloromethyl 2ʹ,7ʹ-dichlorodihy-
drofluorescein diacetate (CM-H2DCFDA, henceforth referred
to as DCFDA) probe (Figures 1c and g) and superoxide
production was assessed using the dihydroethidium (DHE)
probe (Figures 1d and h). The fluorescence of cells
transfected with siDAPK2 or treated with H2O2 was compared
to that of control cells (siNS). The histograms depict typical cell
profiles obtained in each experiment and the bar charts on the
right conglomerate mean percentage of fluorescence normal-
ised to control cells±S.E.M. from three independent experi-
ments. Both DAPK2 depletion and H2O2 treatment resulted in
an increase in general oxidative stress in U2OS (Figure 1c)
and A549 (Figure 1g) cells. The same was observed with
regard to the generation of superoxides, which was elevated
on siDAPK2 depletion and on treatment with H2O2 in both
U2OS (Figure 1d) and A549 cells (Figure 1h).
Having observed a clear induction of ROS (H2O2 and O2
•− )
on silencing DAPK2, we asked whether this led to the
activation of mitogen-activated protein kinases (MAPKs),
which are known to be activated by oxidative stress as part
of a pro-survival response.19 Hence, WBmembranes (Figures
1a and e) were probed with antibodies raised against the
phosphorylated forms of ERK1/2, p38 and JNK. Depletion of
DAPK2, when compared with the siNS control, led to
clear phosphorylation/activation of ERK1/2Thr202/Tyr204 and
JNKThr183/Tyr185 in U2OS and A549 cells, whereas phosphor-
ylation of p38Thr180/Tyr182 was only observed in U2OS cells but
not in A549 lung cancer cells (Figure 1a versus Figure 1e).
Superoxide anion (O2
•− ) is a potentially damaging free
radical, which is converted into less reactive hydrogen
peroxide (H2O2) by enzymes of the superoxide dismutase
(SOD) family. To analyse the effect of DAPK2 depletion on the
expression of SOD1, the predominant cytoplasmic SOD, and
mitochondrial SOD2, cells were transfected as before and
RNAwas subsequently extracted. Therewas significant, albeit
small (o1.5-fold), upregulation of both SOD1 and SOD2
mRNA in U2OS cells (Figure 1b). In contrast, in A549 cells,
SOD1 mRNA was not induced but SOD2 mRNA was greatly
increased (greater than fourfold; Figure 1f).
DAPK2 knockdown increases the levels of mitochondrial
O2
•− and leads to spontaneous mitochondrial membrane
depolarisation. Silencing DAPK2 in two different cell lines
led to upregulation of cellular ROS, downstream activation of
MAPKs and upregulation of mitochondrial SOD2, whereas
SOD1 was only slightly upregulated in one of the cell lines
(U2OS). We, therefore, asked whether the source of oxidative
stress were mitochondria. Indeed, the production of ATP by
oxidative phosphorylation is a major source for mitochondrial
ROS, and mitochondrial proton and electron leaks can impact
on mitochondrial coupling efficiency and lead to increased
production of mitochondrial ROS.20 MitoSOX Red (Molecular
Probes) was used to assess mitochondrial O2
•− levels since it
selectively targets mitochondria and is exclusively oxidised
by O2
•− (Figure 2). Cells were transfected as before and
treatments with H2O2 or the mitochondrial complex I inhibitor
1-methyl-4-phenylpyridinium (MPP+) iodide served as posi-
tive controls for the experiment. Unsurprisingly, both treat-
ments increased the levels of mitochondrial O2
•− (Figures 2a
and e). As hypothesised, RNA interference (RNAi)-mediated
depletion of DAPK2 resulted in a small but statistically
significant increase of mitochondrial O2
•− in U2OS (Figures
2b and c) and A549 cells (Figures 2f and g) compared with
siNS-transfected cells.
Another potential source for cellular ROS is the endoplas-
mic reticulum (ER) where the transcription factor CCAAT-
enhancer-binding protein homologous protein (CHOP) is
specifically activated on ER stress.21 To induce ER stress
we used tunicamycin,22 which induced the expression of
CHOP in both U2OS (Figure 2d) and A549 cells (Figure 2h). In
contrast, DAPK2 knockdown did not increase CHOP expres-
sion in either cell line (Figures 2d and h).
Elevated levels of mitochondrial O2
•− can be both a cause
and a consequence of mitochondrial depolarisation,23 which
is involved in apoptosis and inflammation.24,25 To study the
effect of DAPK2 depletion on mitochondrial membrane
potential (Δψm), the JC-1 probe was used. U2OS and A549
cells were transfected with either siNS, or siDAPK2 and, as a
control for Δψm depolarisation, cells were treated with
carbonyl cyanide 3-chlorophenylhydrazone (CCCP), and
then analysed by flow cytometry. Two distinct cell populations
were identified after gating the depolarised population that
resulted from CCCP treatment: one with intact mitochondria
and another that harboured cells with depolarised mitochon-
dria. Depletion of DAPK2 led to ~ 50% more depolarised
mitochondria in both U2OS (Figures 3a–c) and A549 cells
(Figures 3g–i), when compared with control cells. This
pattern can also be seen in the histograms in Figures 3d, e,
j and k. After normalising the absolute fluorescence of cells
on DAPK2 knockdown to that of siNS-transfected cells,
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Figure 1 DAPK2 depletion induces oxidative stress, phosphorylation of MAPKs and transcription of SODs. U2OS (a–d) and A549 (e–h) cells were transfected with either
siNS or DAPK2 siRNA. Forty-eight hours after transfection, the efficacy of DAPK2 silencing and phosphorylation of ERK1/2, JNK and p38 were assessed by SDS-PAGE/qWB
using Lamin B and HSP90 as loading controls (a and e), and the induction of SOD1 and SOD2 mRNAwas measured by qPCR (b and f). Data represent mean± S.E.M. of three
independent experiments. Statistical analyses were done using Student’s t-test (paired, one tailed) (Po0.05). Oxidative stress was detected by flow cytometry. Cells were
transfected with siNS or siDAPK2 for 48 h, and H2O2 treatment (0.5 mM, 24 h) was used as a positive control for ROS production. The DCFDA probe was used to detect general
ROS in U2OS (c) and A549 cells (g), whereas O2
•− anions were detected in U2OS (d) and A549 cells (h) using the DHE probe. Staining intensity was quantified using geometric
means of three independent experiments and plotted as fold change in relation to the siNS-transfected cells. Statistical analysis was done using Student’s t-test (paired, one tailed)
(*Po0.05, **Po0.01)
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a significant overall increase in green fluorescence, a read-
out for decreased Δψm, was measured in both cell lines
(Figures 3f and l), suggesting that DAPK2 ablation increased
spontaneous mitochondria depolarisation. This was con-
firmed using tetramethylrhodamine ethyl ester (TMRE),
another mitochondrial probe (Figure 4).
Treatment with mitochondrial complex inhibitors leads to the
activation of DAPK1 and a decrease in Δψm2. As shown in
Figure 3m A549 cells depleted of DAPK2 have reduced
DAPK1 phosphorylated on S308, which is an inactivating
phosphorylation event that modulates DAPK1 activity. This
suggested that silencing DAPK2 led to the activation of
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Figure 2 DAPK2 knockdown triggers mitochondrial O2
•− production. U2OS (a–d) and A549 (d–h) cells were transfected with either siNS or DAPK2 siRNA. Forty-eight hours
later, mitochondrial O2
•− levels were assessed using the MitoSOX Red probe. U2OS (a and b) and A549 (e and f) cells were also treated with H2O2 (0.5 mM) or MPP
+ (1 mM),
which were used as positive controls, for 24 h. The average of geometric means of four independent experiments was plotted as fold change (siNS versus siDAPK2) (c and g).
Statistical analysis was done using Student’s t-test (paired, two tailed) (*Po0.05). ER stress was assessed 48 h after siRNA transfection by SDS-PAGE/qWB using CHOP
expression as a read-out (d and h). The induction of CHOP protein following treatment with tunicamycin (0.5 μg/ml) served as positive control and HSP90 expression was used as
a loading control
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DAPK1. Interestingly, U2OS cells did not express DAPK1
protein or mRNA (data not shown). Thus, although mitochon-
drial depolarisation in A549 cells might be associated with
activation of DAPK1, in U2OS cells this is unlikely.
Altered mitochondrial integrity leads to metabolic
changes. The increase in mitochondrial O2
•− production
and spontaneous mitochondrial depolarisation after DAPK2
silencing suggested that mitochondria were the likely source
of ROS. The data were consistent with a significant
impairment of mitochondrial integrity in response to DAPK2
depletion and, in the case of A549 lung cancer cells,
activation of DAPK1. The metabolic consequences of these
mitochondrial alterations in DAPK2-depleted cells were,
therefore, investigated next.
Eukaryotic cells use two key metabolic pathways for ATP
generation (Figure 5a). Both pathways start with glycolysis
as the first step of glucose metabolism, converting one
glucose molecule into two molecules of pyruvate with gain of
two ATP molecules. Aerobic respiration involves the trans-
port of pyruvate into the mitochondria and mitochondrial
respiration downstream of glycolysis through the tricarboxylic
acid (TCA)/Krebs cycle, which yields another thirty four ATP
molecules/molecule of glucose.26 Anaerobic respiration
includes glycolysis and the fermentation of pyruvate to
lactate, a metabolic pathway that bypasses mitochondrial
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Figure 3 Genetic ablation of DAPK2 increases the rate of spontaneous mitochondrial membrane depolarisation using the JC-1 probe. U2OS (a–f) and A549 (g–m) cells were
transfected with either siNS or siDAPK2. Forty-eight hours after transfection cells were incubated with JC-1 and the fluorescence of J-aggregates or monomers was measured in
red and green fluorescence channels by flow cytometry. CCCP (50 μM) was used to induce complete mitochondrial depolarisation (c and i) and to set appropriate gates in U2OS
(a–c) and A549 cells (g–i) used for the quantification of mitochondrial depolarisation following transfection with siNS (a and g), or siDAPK2 (b and h). Overall green fluorescence
(FITC) data is also presented in histograms (U2OS: d and e; A549: j and k). Staining intensity was quantified using geometric means of three independent experiments and
plotted as fold change (f and l). Data represent mean± S.E.M. of three independent experiments and the statistical analysis was done using Student’s t-test (paired, one tailed)
(*Po0.05). The phosphorylation of DAPK1 on Ser308 and DAPK1 expression levels were analysed in A549 lung cancer cells by SDS-PAGE/qWB, using HSP90 as a loading
control (m)
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respiration, and is predominantly upregulated in cancer cells
(Warburg effect), which cancer cells use to produce most of
their energy.18,27
Changes in aerobic and anaerobic respiration were
analysed by measuring the oxygen consumption rate (OCR),
an accurate indicator of mitochondrial respiration, and the
extracellular acidification rate (ECAR), an indirect measure-
ment of lactic acid production, with a Seahorse XF96 analyser
(Seahorse Bioscience, North Billerica, MA, USA; Figure 5).
OCR and EACR were determined under basal conditions in
siDAPK2- or siNS-transfected cells. The EACR in siDAPK2-
tranfected cells, measured inmpH/min, was normalised to that
in siNS-transfected control cells. No statistically significant
changes in EACRs were detected between siNS- and
siDAPK2-transfected U2OS (Figure 5b), or A549 (Figure 5h)
cells, suggesting that silencing DAPK2 did not skew metabo-
lism in these cells towards anaerobic respiration. OCR was
measured in pMoles/min and normalised as described above
for EACR measurements. In contrast to what was seen for
EACR, there was a significant decrease in OCRs by
mitochondria on DAPK2 knockdown in both U2OS
(Figure 5c) and A549 (Figure 5i) cells, suggesting that DAPK2
modulated mitochondrial respiration but not anaerobic
respiration.
To investigate further the consequences of DAPK2
depletion on cellular metabolism, levels of the coenzymes
nicotinamide adenine dinucleotide (NAD+) and nicotinamide
adenine dinucleotide phosphate (NADP+), as well as their
corresponding reduced forms (NADH and NADPH, respec-
tively), were analysed. During glycolysis and the TCA cycle,
each glucose molecule leads to the reduction of six NAD+ to
NADH, which are then oxidised during oxidative respiration to
produce ATP.26 In contrast to NADH, NADPH is not involved
in metabolic processes but it has an important role in the
regeneration of oxidised glutathione (GSH), a key antioxidant
in cells.28 Colorimetric assays were used to determine the
levels of NAD+ and NADH, as well as NADP+ and NADPH.
MPP+ was used to inhibit oxidative phosphorylation and
increase the levels of NAD+ and NADH. As shown for U2OS
(Figures 5d and e) and A549 cells (Figures 5j and k), the
control MPP+ treatment increased the levels of NAD+ and
NADH (albeit in A549 cells the increase in NADH was small
and not statistically significant). However, NAD+/NADH
levels remained unaffected by DAPK2 knockdown. Interest-
ingly, the levels of NADP+ and NADPH in U2OS cells (Figures
5f and g) appeared slightly decreased on silencing DAPK2,
whereas there was no detectable change in A549 cells
(Figures 5l and m). The data thus suggested that RNAi-
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Figure 4 Measurement of spontaneous mitochondrial membrane depolarisation after transfection with siDAPK2 using the TMRE probe. U2OS (a–c) and A549 (d–f) cells
were transfected with either siNS or siDAPK2. Forty-eight hours after transfection cells were incubated with TMRE and the fluorescence intensity in the red fluorescence channel
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Figure 5 The absence of DAPK2 leads to reduced oxidative phosphorylation in U2OS and A549 cells. (a) Simplified cartoon depicting cellular metabolism pathways with
glycolysis as the first step of glucose breakdown, and oxidative phosphorylation and anaerobic respiration as subsequent steps. To quantify cellular metabolic processes, U2OS
(b–g) and A549 (h–m) cells were transfected with either siNS or DAPK2 siRNA. Forty-eight hours after transfection cells were analysed using a Seahorse Analyser. ECAR, an
indirect measurement of lactic acid production, is depicted as fold change of mpH/min and normalised to siNS control in U2OS (b) and A549 cells (h). OCR, which can be used to
determine mitochondrial respiration, is shown as fold change of pmol/min and normalised to siNS control in U2OS (c) and A549 cells (i). Forty-eight hours after siRNA
transfection, NAD+, NADH, NADP+ and NADPH levels were analysed using colorimetric assays in U2OS (d–g) and A549 cells (j–m). Treatment with MPP+ (1 mM, 24 h) served
as a positive control. Data represent mean± S.E.M. of three independent experiments, statistical analyses were done using Student’s t-test (paired, one tailed) (*Po0.05,
**Po0.01)
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mediated ablation of DAPK2 affected oxidative phosphoryla-
tion without substantially impacting on NAD+/NADH or
NADP+/NADPH metabolism.
Depletion of DAPK2 leads to decreased GSH levels and
induction of NRF2. Having established that genetic ablation
of DAPK2 led to changes in cellular oxidative stress,
mitochondrial respiration, activation of stress kinases and
upregulation of SODs in two distinct cancer cell types, we
next asked what effect downregulation of DAPK2 had on the
levels of GSH, which functions as an electron donor and is
involved in the reduction of cellular ROS.29,30 In fact, the
generation of oxidised GSH (GSSG) is tightly linked to
mitochondrial oxidative phosphorylation, whereby NADPH
reduces GSSG to GSH. To assess total GSH level, cells were
transfected as described earlier and a subtle, but statistically
significant, downregulation of GSH levels on DAPK2 knock-
down was detected, which was more prominent in U2OS
(Figure 6a) than in A549 cells (Figure 6e).
The question was whether such small reductions in GSH
levels were sufficient to induce nuclear factor (erythroid-
derived 2)-like 2 (NFE2L2/NRF2), which is responsible for the
transcription of a multitude of antioxidants that protect cells
from oxidative stress. NRF2 binds to the antioxidant response
element, leading to transcriptional activation of GSH synthe-
sising enzymes and other antioxidant enzymes, such as
SOD1 and SOD2, which were upregulated on DAPK2
silencing (Figures 1b and f). After U2OS and A549 cells were
transfected with siDAPK2 or siNS, RNA and proteins were
extracted and the levels of NRF2 and its ubiquitin ligase kelch-
like ECH-associated protein 1 (KEAP1) analysed. Interest-
ingly, NRF2 mRNA levels were significantly elevated in U2OS
cells (Figure 6b), but not in A549 cells (Figure 6e). KEAP1 was
not induced in either U2OS (Figure 6c) or A549 cells
(Figure 6f).
The mitochondrial-associated function of DAPK2 is likely
to be kinase mediated. The data thus far suggested that the
increase in intracellular ROS caused by downregulating
DAPK2 was due to an impairment of mitochondrial functions.
To understand how DAPK2 preserved mitochondrial integrity,
the relevance of DAPK2’s kinase domain was investigated.
For that purpose, tetracycline (Tet)-inducible U2OS cell lines
(U2OS-TetR) containing HA-tagged DAPK2 constructs that
were either wild-type (HA-DAPK2.wt) or kinase-dead (HA-
DAPK2.K42A)6 were used. The caveat with this approach is
that it was impossible to express the constructs at endogen-
ous levels and overexpression of DAPK2 is sufficient to
induce apoptotic features.6 This approach could not thus be
used experimentally to rescue the phenotype observed after
RNAi targeting DAPK2. It did, however, enable analysis of the
role of the kinase domain on the regulation of intracellular
oxidative stress.
Transgene expression was induced in HA-DAPK2.wt
(Figure 7a) and HA-DAPK2.K42A cells (Figure 7c) using
doxycycline (Dox) and ROS levels were measured using
DCFDA. As expected from previously published work, over-
expression of wild-type DAPK2, rather than leading to reduced
oxidative stress, led to an increase in general ROS production
(Figure 7b), but importantly this was not observed if cells
overexpressed a kinase-dead DAPK2 mutant (Figure 7d).
The overexpressed kinase-deadmutant (HA-DAPK2.K42A)
did not behave as a dominant-negative and did not mimic the
phenotype caused by DAPK2 silencing (Figure 7d). This might
be due to the cells still expressing endogenous wild-type
DAPK2. To eliminate the endogenous wild-type DAPK2 in the
inducible cell model, 3′UTR-specific siRNAs were used.
These molecules exclusively target endogenous DAPK2
(Figures 7e–h).9 Cells were transfected with either siNS or 3′
UTR-specific DAPK2 siRNA (henceforth siDAPK2–3′UTR)
and to induce HA-DAPK2.K42A expression cells were
stimulated with Dox as they were being transfected. As shown
in Figure 7e, siDAPK2–3′UTR specifically targeted endogen-
ous DAPK2 and did not impact on the expression of kinase-
dead DAPK2, which was detected using an anti-HA antibody.
Having established a cell system where it was possible to
efficiently downregulate endogenous DAPK2 and concomi-
tantly overexpress a kinase-dead DAPK2 mutant enabled
studying the effect of kinase-dead DAPK2 on the generation of
general ROS. Consistent with our previous results (Figure 1c),
depletion of wild-type DAPK2 without (Figure 7g, grey line) or
with overexpression of kinase-dead DAPK2 (Figure 7g, dotted
line), using siDAPK2–3′UTR, led in both cases to a significant
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Figure 6 Ablation of DAPK2 leads to decreased GSH levels, and in U2OS cells to
the induction of NRF2 mRNA. U2OS (a–c) and A549 (d–f) cells were transfected with
either siNS or siDAPK2, and the levels of GSH were analysed using a colorimetric
assay 24 h later (a and d). NRF2 (b and e) and KEAP1 (c and f) mRNA levels were
assessed by qPCR. Data represent mean± S.E.M. of at least three independent
experiments and the statistical analyses were done using Student’s t-test (paired, one
tailed) (*Po0.05, ***Po0.005)
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Figure 7 Effect of wild-type (wt) and kinase-dead (K42A) DAPK2 overexpression on oxidative stress. The expression of HA-tagged wild-type (wt) or HA-tagged kinase-dead
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increase in ROS (Figures 7g and h). The overexpression of
kinase-dead DAPK2, importantly, actually led to a significantly
higher level of oxidative stress in U2OS cells than the wild-type
endogenous protein (Figure 7h). In control cells transfected
with siNS, the level of oxidative stress was the same
regardless of the presence or absence of HA-DAPK2.K42A
(Figure 7f). Collectively, our data suggested that DAPK2
kinase activity was important for preserving mitochondria’s
integrity and protecting cells from oxidative stress.
Discussion
Although DAPK1–3 are structurally different, both DAPK2 and
DAPK3 evolved from DAPK1,31 which regulates mitochondrial
integrity2 and metabolic processes.3 Given the common
ancestry and sequence homology within DAPKs’ kinase
domains, common mechanisms of action and functional
redundancy have been postulated.32 Indeed, all three have
been associated with apoptotic processes and thought to be
potential tumour suppressors.18
Here we show that depletion of DAPK2 results in ROS
generation (Figures 1c, d, g and h), induction of SODs (Figures
1b and f) and phosphorylation/activation of MAPKs (Figures
1a and e). Mitochondrial SOD2 was induced more than
cytosolic SOD1 (Figures 1b and f), suggesting that in the
absence of DAPK2, increased levels of ROS were produced
by mitochondria.13 Additional experiments support this
hypothesis (Figures 2a–c and e–g) and indicate that the ER
is an unlikely additional ROS source (Figures 2d and h).
Silencing DAPK2 leads to increased spontaneous mitochon-
drial depolarisation (Figures 3a–l and Figure 4), and in A549
cells to the activation of DAPK1 (Figure 3m), thought to be a
Δψm sensor involved in cytoskeletal rearrangements respon-
sible for mitochondrial transport mechanisms.2 DAPK1 and
DAPK2 have also been reported to heterodimerise.32 It is thus
reasonable to assume that they may operate similarly with
regard to mitochondrial maintenance, sensing the mitochon-
drial membrane potential and leading to downstream pro-
cesses of mitophagy and mitochondrial degradation, which
result in faulty mitochondria. Interestingly, neither overexpres-
sion of DAPK1 nor DAPK2 has been shown to induce
mitochondrial depolarisation.6 Immunofluorescence analyses
using MitoTracker Red did not suggest any obvious mitochon-
drial morphological changes in cells devoid of DAPK2 (data
not shown).
DAPK2 knockdown leads to significantly reduced oxidative
phosphorylation without affecting lactic acid fermentation
(Figures 5b, c, h and i). This suggests a fundamental role for
DAPK2 in the regulation of mitochondrial metabolism and/or
maintenance. This, in turn, raises the question of how these
cells maintain their energy supply, without increased lactic
acid fermentation, DAPK2-depleted cells are unlikely to be
compensating the decrease in oxidative phosphorylation via
anaerobic respiration (Figure 5a). Consistent with this, no
significant changes in NAD+/NADH and/or NADP+/NADPH on
DAPK2 silencing are seen (Figures 5d–g and j–m). All
experiments were performed 48 h post RNAi. Thus, eventual
cellular compensatory mechanisms, such as increased
glycolytic rate or lactic acid production, may not yet be
detectable. For example, it has been shown that inhibition of
the mitochondrial electron transport by low doses of ethidium
bromide for 4 days causes NADH accumulation, halts the
TCA cycle and drives cells towards anaerobic glucose
metabolism.33
The ROS increase and mitochondrial depolarisation were
accompanied by a small, statistically significant, GSH
decrease (Figures 6a and d), and in U2OS cells by the
induction of NRF2 (Figure 6b). There was no induction of
NRF2 in A549 cells (Figure 6e) and the levels of KEAP1, a
NRF2 regulator,34 remained unchanged in both cell lines
(Figures 6c and f). SOD2 protein expression levels, unlike
what was observed at the mRNA level, did not vary with the
downregulation of DAPK2 expression. In fact, the expression
of GCLC, GPX1, GSTpi and GSS, enzymes involved in GSH
metabolism, did not change significantly either on RNAi
against DAPK2 (data not shown). These data thus suggest
that it is their enzymatic activity that matters, which is
corroborated by the GSH quantification shown in Figures 6a
and e, used as an indirect read-out for these enzymes.
Overexpression of HA-tagged wild-type DAPK2 per se
increases the levels of intracellular ROS in U2OS cells (with
endogenous DAPK2), whereas kinase-dead DAPK2 does not
(Figures 7a–d). In contrast, as previously shown,6 over-
expression of wild-type DAPK2 does not induce mitochondrial
ROS (data not shown). Interestingly, overexpression of the
kinase-dead mutant, in the absence of endogenous DAPK2,
leads to increased oxidative stress and this is greater than that
seen with the wild-type protein (Figures 7e–h). Collectively,
these data indicate that DAPK2 kinase activity is important for
preserving mitochondrial integrity and protecting cells from
oxidative stress.
DAPK2 is emerging as a tumour suppressor in several types
of cancer cells, especially in acute promyelocytic leukaemia,
which responds to treatment with all-trans retinoic acid
(ATRA).12 This is interesting as ATRA leads to increased
DAPK2 expression. Given the role of ROS in the aetiology of
AML,35 downregulation and/or loss of DAPK2 likely benefits
cancer cells by leading to deregulated mitochondria,
increased cellular ROS and, thus, genomic instability. Indeed,
somatic mitochondrial mutations and accumulated mitochon-
drial damage have been linked to AML development.36
Despite its relatively small size and straightforward structural
features, DAPK2 appears to be a double-edge sword,
depending on cellular context and interaction partners.
Indeed, recently, we have shown that downregulation of
endogenous DAPK2 activates NF-κB and sensitises multiple
cancer cell types to TRAIL-induced apoptosis but not to other
cytotoxic stimuli.9 NF-κB, another multi-faceted protein, can
also be activated by oxidative stress but TRAIL-induced
apoptosis appears to be independent of oxidative stress since
it can be blocked by caspase inhibitors (Supplementary Figure
S2), but these inhibitors do not impair the production of ROS
(Supplementary Figure S3) or mitochondrial depolarisation
(Supplementary Figure S4) seen after DAPK2 depletion.
Experiments using U2OS cells that express LC3–GFP (an
autophagy readout) suggest that depletion of DAPK2 also
affects autophagy, as in these cells nutrient starvation leads to
an increase in the expression of LC3I (data not shown). It is still
unclear if this directly impairs mitochondrial recycling, leading
to the accumulation of ‘faulty’ mitochondria, and if it
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contributes for the oxidative stress measured here. This is
entirely consistent with a novel report by Kimchi and co-
workers,37 where it is shown that DAPK2 is a novel mTORC1
kinase and therefore a novel regulator of autophagic pro-
cesses. How this relates to the regulation of NF-κB9 remains
under scrutiny.
We have thus identified a novel role for DAPK2 in the
regulation of mitochondrial integrity, as its absence leads to
mitochondrial depolarisation and increased oxidative stress.
This may be a mechanism by which, depending on the
intracellular context, DAPK2 can act as a tumour suppressor
gene. Importantly, as the effect of DAPK2 silencing on
mitochondrial respiration is conserved betweenmesenchymal
U2OS cells and epithelial A549 cells, it is likely that our
findings can be further extended to additional cell lineages and
malignancies.
Materials and Methods
Cell culture. U2OS and A549 cells were grown in Dulbecco’s Modified Eagle’s
medium (DMEM) supplemented with 10% (v/v) foetal calf serum (FCS) (FirstLink,
Wolverhampton, UK), 2 mM L-glutamine, 50 U/ml penicillin and 50 μg/ml
streptomycin (henceforth referred to as ‘complete DMEM’), in a humidified
atmosphere of 10% CO2 at 37 °C. The U2OS-TetR cell line was provided by
Professor SA Johnsen38 and cultured in full DMEM media supplemented with
5 μg/ml blasticidine S hydrochloride. All chemicals were from Sigma-Aldrich (St.
Louis, MO, USA), unless otherwise specified.
Plasmids. N-terminal HA-tagged wild-type and kinase-dead (K42A) DAPK2
pcDNA3 plasmids were kindly provided by Kimchi and co-workers.6 Both constructs
were sub-cloned using BamHI and XhoI restriction sites into a pcDNA4/TO vector,
which is part of the Tet-inducible mammalian expression system, T-REx System
(Life Technologies, Paisley, UK).
Generation of stable inducible cell lines. HA-tagged DAPK2 wild-type
and kinase-dead (K42A) constructs, cloned into the pcDNA4/TO vector, were
linearised using the restriction enzyme PvuI (New England Biolabs, Hitchin, UK)
and transfected into U2OS-TetR cells using Lipofectamine 2000 (Life Technologies),
as instructed by the manufacturer. Forty-eight hours later, cells were re-plated and
incubated with complete DMEM supplemented with 5 μg/ml blasticidine S
hydrochloride and 500 μg/ml Zeocin (Life Technologies). Individual clones were
isolated using cloning cylinders and tested for induction of the transgene and
background expression by SDS-PAGE/qWB. For each construct, at least five
inducible clones were generated and tested.
Antibodies. The anti-DAPK2 antibody was purchased from Epitomics
(Burlingame, CA, USA); anti-phospho-DAPK1 (Ser308) and DAPK1 from Abcam
(Cambridge, UK); antibodies against phospho-ERK1/2 (Thr202/Tyr204), phospho-
p38 MAPK (Thr180/Tyr182), phospho-JNK (Thr183/Tyr185) and CHOP from Cell
Signaling Technology (Cambridge, UK); antibodies against HA, β-actin and α-
tubulin from Sigma-Aldrich; anti- HSP90 (HSP86) from NeoMarkers (Fremont, CA,
USA); antibodies against ERK1/2 and Lamin B were from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Anti-mouse and anti-rabbit secondary antibodies were from
DAKO (Glostrup, Denmark) and the anti-goat antibody was from Sigma-Aldrich.
RNA interference. RNAi was performed using Lipofectamine RNAiMax (Life
Technologies), essentially as described in ref. 39. For forward siRNA transfection
cells, plated at a density of 2.5 × 105 in six-well plates, were left untransfected, or
were transfected with either 20 nM AllStars non-targeting control siRNA (siNS)
(Qiagen, Hilden, Germany), 20 nM of a siDAPK2 pool (siRNA oligonucleotides 3
and 4 from Dharmacon, Lafayette, CO, USA) or with either of two different 3′UTR-
specific siRNAs (from Dharmacon or Qiagen). Cells were then treated and analysed
as described in the figures using methods described below. Reverse siRNA
transfections were carried out in 10 cm dishes using 5 × 105 cells in suspension
(8 ml). Cells were left untransfected or were mixed with transfection reagent and
either 20 nM siNS or siDAPK2. All siRNA oligonucleotide sequences are listed on
Supplementary Table SI.
Protein expression analysis. Proteins were extracted using radioimmuno-
precipitation assay buffer (50 mM Tris-HCl pH 7.4; 0.5% (v/v) NP-40, 150 mM NaCl,
1 mM EDTA, 1 mM Na3VO4 and cOmplete and Mini, EDTA-free protease inhibitor
cocktail, the latter used as instructed by the manufacturer (Roche, Mannheim,
Germany)). Concentrations were determined using a Bradford assay according to
the manufacturer’s instructions (BioRad, Hercules, CA, USA). They were then
analysed by SDS-PAGE/ qWB. Membranes were blocked using 5% (w/v) non-fat
milk/TBS-Tween 20, which was the buffer also used to dilute secondary antibodies.
Primary antibodies were diluted in 5% (w/v) BSA/ TBS-Tween 20. WBs were
analysed using the quantitative luminescence system FUSION Solo (PEQLAB,
Sarisbury Green, UK). Images were analysed using Image Studio Lite software
(LI-COR Biosciences, Lincoln, NE, USA) (www.licor.com/islite). The WB images
have been cropped for clarity purposes: that has in no way altered the essence of
the data obtained in three independent experiments.
Detection of oxidative stress by flow cytometry. Cells were cultured
in six-well plates and transfected with siRNA oligonucleotides as described before,
or treated with 0.5 mM H2O2 for 24 h, which was used as a positive control for ROS
production. General ROS were detected using CM-H2DCFDA (Molecular Probes,
Life Technologies, Paisley, UK; referred throughout the text as DCFDA). For that
purpose, cells were incubated with 10 μM DCFDA dissolved in pre-warmed PBS for
30 min at 37 °C. Cells were then trypsinised, resuspended in complete DMEM,
washed twice with PBS and analysed by flow cytometry. Cellular superoxide anions
were detected using DHE (Molecular Probes) 48 h after transfection. Essentially,
cells were trypsinised, resuspended in complete DMEM, washed twice with PBS,
incubated in 10 μM DHE dissolved in pre-warmed PBS for 15 min and analysed by
flow cytometry. Mitochondrial superoxide anions were measured using the MitoSOX
Red mitochondrial superoxide indicator. Briefly, cells were transfected as described
earlier, or they were treated for 24 h with 1 mM MPP+, or with 0.5 mM H2O2, the
latter two used as positive controls. Forty-eight hours later, cells were washed with
PBS and incubated for 10 min at 37 °C in the dark with 5 μM MitoSOX Red reagent
diluted in pre-warmed PBS. Samples were subsequently washed twice with PBS
before being analysed. Depolarised mitochondria were quantified using the
MitoProbe 5ʹ,6,6ʹ-tetrachloro-1,1ʹ,3,3ʹ-tetraethylbenzimidazolylcarbocyanine iodide
(JC-1) Assay Kit and Tetramethylrhodamine, ethyl Ester, perchlorate (TMRE;
Molecular Probes). For JC-1 staining, 48 h after transfection, cells were trypsinised,
resuspended in complete DMEM, washed twice with PBS and incubated with 2 μM
JC-1 dissolved in pre-warmed PBS at 37 °C, 10% CO2 for 15 min and analysed by
flow cytometry. TMRE staining was performed as follows: 48 h after transfection
cells were incubated with 100 nM TMRE dissolved in pre-warmed complete DMEM
at 37 °C, 10% CO2 for 10 min and analysed by flow cytometry. To induce complete
mitochondrial depolarisation, the protonophore CCCP (50 mM) was used for 5 min
prior to the incubation of cells with JC-1 and TMRE.
All flow cytometry analyses were performed using a FACS Canto (Becton
Dickinson, Franklin Lakes, NJ, USA) and data mining was done using FlowJo (Tree
Star, Inc., Ashland, OR, USA). Fluorescence geometric means were used for the
analyses and samples were normalised to siNS-transfected control cells, essentially
as described earlier.39
Induction of ER stress. ER stress was induced using the glycosylation
inhibitor tunicamycin (0.5 μg/ml, 24 h) and monitored by SDS-PAGE/qWB using
CHOP expression as a read-out.
Real-time quantitative PCR. Gene expression analysis was done by
quantitative two-step reverse transcription PCR. Reverse transcription was
performed using total RNA and a High Capacity cDNA Reverse Transcription kit
(Life Technologies), using random hexamers. Quantitative PCR (qPCR) was done
using the Fast SYBR Green Master Mix (Life Technologies) with specific primer
pairs (Supplementary Table SII). For each target mRNA analysed, 2.5 μl of Fast
SYBR Green Master Mix, 0.5 μM of each primer pair and 2 μl of cDNA in deionised
water (5 ng/μl) were mixed in 384-well plates in duplicates using Matrix Equalizer
Electronic Multichannel Pipetters (Thermo Fisher Scientific, Loughborough, UK).
qPCR was carried out on an ABI PRISM 7900HT (Applied Biosystems, Foster City,
CA, USA) using the following settings: initial activation of 20ʺ at 95 °C, 40 cycles;
denaturation for 1ʹ at 95 °C; annealing/extension for 20ʺ at 60 °C; final melting curve
was carried out for 15ʺ at 95 °C and then for 15ʺ at 60 °C. Quantification of target
messages was performed using qbasePLUS software (Biogazelle, Ghent, Belgium).
HPRT and GAPDH were the reference genes used for normalisation.
DAPK2 regulates oxidative stress
CR Schlegel et al
11
Cell Death and Disease
Metabolic analyses. Metabolic measurements were done in real-time, non-
invasively, using a Seahorse XF96 analyser, which measured the OCR and the ECAR
under basal conditions in siDAPK2- or siNS-transfected cells. A cell titration assay was
used to determine a suitable cell plating density for both A549 and U2OS cells. For the
experiment proper, 0.5 × 106 cells were plated per 10 cm dish and reverse transfected
on day 1 as previously described. Forty-eight hours post transfection, cells were re-
plated into the XF96 microplates (Seahorse Bioscience; 4 × 104 cells per 100 μl per
well) and incubated overnight at 37 °C. The XF calibration solution (Seahorse
Bioscience) was added into the XF sensor cartridge (Seahorse Bioscience) and was
also incubated at 37 °C overnight but without CO2. The next day, prior to the assay,
complete DMEM was replaced with an XF Assay Medium Modified DMEM (Seahorse
Bioscience) (1 g/ml glucose, pH 7.4) and cells were incubated at 37 °C for 1 h without
CO2. Analyses were performed according to the manufacturer’s instructions using eight
measurements that the instrument recorded for OCR (nmoles/min) and ECAR (mpH/
min) pertaining to each well. Results were analysed using the provided XFe Wave
software (Seahorse Bioscience).
GSH colorimetric assay. Cells (2.5 × 105 per well in 6-well plates) were
transfected with siRNA oligonucleotides as described earlier. Cell lysates were collected
and sonicated in 50 mM PBS per 1 mM EDTA. Protein concentrations were determined
using a Bradford assay, according to the manufacturer’s instructions, which enabled
subsequent normalisation of each sample so that the final protein concentration was
1 μg/μl. GSH levels in each sample were quantified using the Glutathione Assay Kit
from BioAssay Systems (Hayward, CA, USA), as per the manufacturer’s protocol.
NADH and NADPH assay. Reverse siRNA transfections were carried out in
10-cm dishes using 5 × 105 cells in suspension. As positive control, cells were
treated for 24 h with 1 mM of MPP+. Forty-eight hours after transfection, NADP/
NADPH levels for each sample were quantified using the NADP/NADPH assay kit
(Abcam) and NAD/NADH levels using the NAD/NADH assay kit (BioVision, San
Francisco, CA, USA), according to the two manufacturers’ protocols.
Statistical analysis. Mean±S.E.M. of at least three independent experiments
were used throughout. ANOVA or t-test statistical analyses were carried out as
indicated in each figure legend using GraphPad Prism (GraphPad Software Inc.,
San Diego, CA, USA).
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